Vitamin D3 for Life

Live Enlightened

Article

VDR Cistrome, Chromatin and 3D Genome Organisation: Evidence Synthesis

Previous related pageFunctional Vitamin D Status: Biological Response, Variability and Interpretation: Evidence SynthesisNext related pageVitamin D and Cell Differentiation
Study at a glance

Why can vitamin D affect different genes in different cells?

A cell’s genetic material is packed and folded. That arrangement, together with other regulatory proteins, affects which regions the vitamin D receptor can reach. Access also changes over time.

If a vitamin D receptor attaches, does a gene’s activity always change?

No. Studies found many more places where the receptor attached than genes with an immediate measurable response. Attaching is one step; it does not guarantee that a nearby gene becomes more or less active.

Does the folding of genetic material matter for the vitamin D response?

Experiments found that vitamin D signalling changed some contacts between distant regions of genetic material. Disrupting selected contacts altered gene responses, showing that some of these contacts play a part in how genes respond.

Do these results describe every tissue in the body?

No. Much of this evidence comes from laboratory models of immune cells. It explains ways this could work without establishing the same pattern in every organ or proving a health benefit.

Read the full article below ↓

A VDR molecule can be present in a cell and still have access to only a fraction of the genome. The VDR cistrome (the genomic sites occupied by VDR under a defined condition) is shaped by cell identity, chromatin accessibility, other regulatory factors and three-dimensional chromatin architecture. The strongest evidence comes not from any single map, but from the progression from occupancy mapping to time-resolved chromatin measurements, VDR-loss experiments and direct perturbation of chromatin loops.

Genome-wide occupancy is much larger than the immediate transcriptional response

Ramagopalan and colleagues used ChIP-seq after calcitriol stimulation in a human lymphoblastoid cell model and identified 2,776 genomic positions occupied by VDR. In the same experimental setting, 229 genes showed significant expression changes in response to vitamin D. That numerical separation is important: thousands of receptor-occupied regions do not translate one-for-one into thousands of immediately responsive genes.

The study also moved VDR biology beyond a promoter-centred model. Many binding sites were distal regulatory regions, and the map showed that receptor occupancy has to be interpreted across the genome. But the map was generated in one cell model and at defined stimulation conditions. It is evidence that the cistrome is extensive, not a universal catalogue of VDR sites for every tissue.

Chromatin accessibility changes over time rather than simply switching on

Seuter, Neme and Carlberg examined THP-1 human monocytes across a vitamin-D stimulation time course and found 8,979 loci with significantly modulated chromatin accessibility. Maximal chromatin opening occurred at about 24 hours; by 48 hours, most of those sites had closed again. This makes accessibility a dynamic variable. A site can become more available during one phase of the response and later return toward a less accessible state.

CTCF connected this accessibility response to higher-order regulatory organisation. CTCF occupied about 14% of the vitamin-D-sensitive chromatin regions, and ligand exposure altered CTCF association. The transcriptome was dynamic as well: 1,284 genes were modulated across the time course, with 77.5% responding only at 24 hours, while the fraction of down-regulated genes increased over time. These data make it difficult to describe a single static ‘vitamin D response’. Accessibility, CTCF association and transcription change on different temporal trajectories.

Regulatory-factor context is part of the response, not background noise

Warwick and colleagues integrated VDR cistrome, open-chromatin and transcriptome data in THP-1 cells to build a hierarchical model of primary and secondary regulation. Their analysis predicted 75.6% of early responding genes at 2.5 or 4 hours and 57.4% of late differentially expressed genes at 24 hours to be primary VDR targets. Forty-seven predicted primary targets encoded transcription factors, providing a mechanistic route by which an initial VDR signal could propagate into later regulatory layers.

The study then tested whether the transcriptional response actually required VDR. VDR knockout caused complete loss of the 1,25-dihydroxyvitamin-D3-induced genome-wide transcriptional response in this model. That result is stronger than co-location: it shows that the ligand-induced transcriptional programme measured here was VDR-dependent. CEBPA and ETS1 ChIP-seq data, together with RNA-seq after CEBPA knockdown, were used to validate roles for downstream regulatory factors. Cell identity therefore matters partly because VDR enters an already organised transcription-factor network.

Three-dimensional chromatin adds a functional spatial layer

Warwick and colleagues later used CTCF HiChIP to measure long-range chromatin interactions after VDR activation. Changes were detected in 3.1% of all observed CTCF interactions, corresponding to changes in the frequency of more than 3,000 CTCF interactions. VDR binding was enriched both at differential loop anchors and inside differential loops, while vitamin-D-responsive genes were enriched within those loops and at their anchors.

The changed loops were not all of one type. They included arrangements consistent with TAD-border changes, promoter: enhancer contacts and VDR-responsive insulated neighbourhoods. Of 3,372 differentially expressed genes used in the loop analysis, 2,272 (67.4%) lay within differential CTCF loops. That association does not prove that every loop change causes every expression change, but it ties transcriptional regulation to a measurable spatial context rather than treating the genome as a flat sequence.

CRISPR perturbation moves the 3D evidence beyond description

The 2022 study did not stop with HiChIP correlation. CRISPR interference was used at a VDR/CTCF co-bound loop anchor to test enhancer function, including a functional VDR-linked anchor affecting PTGES2 regulation. The investigators also deleted anchors of differential loops and observed altered vitamin-D regulation of genes within or near those loops. Those experiments do not make every ligand-sensitive loop causal, but they establish that at least some of the measured spatial changes participate functionally in gene regulation.

How the studies fit together

The evidence forms a progression in evidential strength. Ramagopalan establishes the scale and distal nature of VDR occupancy and exposes the gap between binding and transcription. Seuter shows that the accessible regulatory landscape itself changes over time and implicates CTCF. Warwick 2021 demonstrates VDR dependence and embeds the response in a hierarchy of other transcription factors. Warwick 2022 adds a three-dimensional interaction map and perturbational evidence that some loop architecture is functionally relevant. Pike’s synthesis places these primary findings within the broader modern model of enhancer: and chromatin-centred VDR action.

These papers are complementary, but they are not five independent replications of one result. Several of the THP-1 analyses arise from overlapping datasets or the same wider research programme. Their value is cumulative mechanistic resolution, not citation count. Conversely, the earlier lymphoblastoid ChIP-seq map is more independent in model and era, but it cannot supply the later time-resolved, knockout or 3D causal evidence.

What this means for cell-specific VDR action

VDR expression supplies signalling capacity; it does not specify the response by itself. A genomic site has to be available in the relevant cell, receptor occupancy has to occur under the relevant ligand and time conditions, and the local network of transcription factors and chromatin contacts can alter what that occupancy means. The result is a cistrome and transcriptome that are conditional on cell state rather than intrinsic properties of the receptor alone.

The inference boundary is equally important. These experiments are heavily based on lymphoblastoid or THP-1/monocyte systems. They establish mechanisms by which cell context can shape VDR action; they do not prove that the exact same 8,979 accessibility sites, transcription-factor hierarchy or loop changes occur in every VDR-expressing tissue.

For the wider transcriptional framework, see Vitamin D and Gene Expression.

Primary evidence used in this synthesis

  • The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J Clin Invest. 2017;127(4):1146 to 1154. DOI: 10.1172/JCI88887.
  • A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution · Genome Res. 2010;20(10):1352 to 1360. DOI: 10.1101/gr.107920.110.
  • Epigenome-wide effects of vitamin D and their impact on the transcriptome of human monocytes involve CTCF · Nucleic Acids Res. 2016;44(9):4090 to 4104. DOI: 10.1093/nar/gkv1519.
  • A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes · Sci Rep. 2021;11:6518. DOI: 10.1038/s41598-021-86032-5.
  • Nuclear receptor activation shapes spatial genome organization essential for gene expression control: lessons learned from the vitamin D receptor · Nucleic Acids Res. 2022;50(7):3745 to 3763. DOI: 10.1093/nar/gkac178.

Related reading

Original sources

Source

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes

The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).

Publication details

A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes · Sci Rep. 2021;11:6518. DOI: 10.1038/s41598-021-86032-5.

Read more →